FBL-mediated rRNA 2’-O-methylation promotes ribosome biogenesis and translational efficiency; dysregulation of this modification enhances oncogenic protein synthesis and has been increasingly recognized as a driver of cancer progression. This evidence concerns the gene FBL and cancer.